Trial Profile
Role of Estrogens in osteoclastogenesis and immunomodulation of T cells.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2012
Price :
$35
*
At a glance
- Drugs Estradiol/norethisterone (Primary) ; Raloxifene (Primary) ; Calcium carbonate; Hormonal replacements
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 11 Jul 2012 Novartis, Daiichi Sankyo Company and Italfarmaco added as associations as reported in the European Clinical Trials Database record.
- 04 Aug 2011 New trial record